Logo1
OH - Advances in the Management of Oncology Patients
Mr pencil

How would you like your name to appear on your certificate?



What activities did you attend at the event?
Agreement
By completing this form, you attest that you have participated in all selected activities in thier entirety.
Please rate the following:
The program was relevant to my work.
Content matched stated objectives.
Usefulness of handouts/AV.
Quality of facilities.
How well did the educational sessions give a balanced view of therapeutic options, including the use of generic names?
If you rated any of the above questions with 'fair,' 'poor,' 'disagree,' or 'strongly disagree' please explain:
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Objective 1: Identify current and emerging therapies for pediatric and adult complex cancers, as well as management strategies to maximize patient outcomes.
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
Objective 2: Discuss the use of screening and diagnostic technologies and recognize cancer patients with complex oncologic problems who require specialized care.
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
Having completed the activity, please rate your ability to meet each of the following objectives:

Identify possible causes of infertility in pediatric cancer survivors.

Discuss fertility preservation options that are available for both male and female cancer patients.

By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.

Identify the risk factors of cancer treatment for both the mother and developing fetus.

Discuss management strategies for pregnant women that are being treated for cancer.

Identify gaps in knowledge regarding the long-term effects of cancer on survivors and their caregivers.

Discuss quality-of-life issues experienced by cancer patients and their caregivers and approaches on how to best manage these issues.

Discuss the importance of communication in relation to complementary and alternative (CAM) therapies

Outline the goals of palliative care for the cancer patients.

List palliative care specialized services for the cancer patient that help families cope with difficult decisions and improve their quality of life.

Outline radiation oncology treatments and their outcomes.

Explain the process of radiation therapy, including how it is utilized to treat a variety of cancers, and discuss future directions in this field.

Discuss complex issues with which cancer survivors are faced after their cancer treatment and the resources available to assist them in improving their quality of life.

State the difference between short and long term survivorship challenges.

Discuss the challenges we face in our current clinical trial system, including recruitment, informed consent and scientific integrity.

Discuss how targeted therapies that are taken orally have impacted cancer treatment for cancer patients.

Outline challenges associated with oral treatment regimens for cancer patients.

Discuss methods of detecting and diagnosing pancreatic cancer.

Describe current treatment options for patients with pancreatic cancer.

Discuss the clinical utility of targeted therapy in treatments for advanced renal cell carcinoma.

Identify the factors that are prognostic for longer overall survival in patients with renal cell carcinoma.

Identify ways to differentiate among high-, intermediate- and low-risk groups of prostate cancer.

State current treatment modalities for the different stages of prostate cancer.

Discuss healthy lifestyle behaviors that promote quality of life in breast cancer patients.

Advise breast cancer patients on strategies to promote adherence to the medical regimen and survivorship care plan.

Discuss various therapeutic options for the treatment of colorectal cancer with liver metastases and their outcomes.

Describe the specific characteristics, staging, prophylaxis and management of non-small cell lung cancer.

Review the latest treatment options for eacah stage of non-small-cell lung cancer, including newer targeted therapies.

Discuss the evolving role of proteasome inhibitors as part of primary therapy for patients with multiple myeloma.

Discuss whether the role of autologous transplantation will change as more effective treatment for myeloma becomes available.

Recognize the clinical factors suggestive of a hereditary cancer syndrome.

Identify the genes associated with hereditary cancers.

Explain the advantages and disadvantages of genetic testing for hereditary cancer susceptibility.

List the stages of neuroblastoma.

Outline criteria used for risk stratification and treatment of neuroblastoma.

Discuss management strategies directed at the long-term effectis of cancer treatment that can materially affect the future health of pediatric cancer patients.

Discuss causes of childhood leukemia and treatments that are tailored to decrease the taxic effects of therapy and improve outcomes.

List the different types of non-Hodgkin lymphoma in children, how it is staged, and the treatment and their outcomes.

List the NIH National Center of CAM domains (NCCAM).
Describe examples of each of the  NIH-NCCAM domains: evidence based indications, contraindications and opportunities
Objective 4: Analyze the importance of comparative effectiveness research of medical treatments to enhance value for patients and the health care delivery system.
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
Objective 5: Describe cancer survivorship and how patients may best navigate the complex issues they face after treatment.
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
Please answer the following:
Do you believe this activity was appropriate for the scope of your professional activities?
Was the educational content scientifically sound?
Was the educational content free of commercial bias?
Was the mode of education effective to learning?
If faculty spoke about off-label or investigational uses of a product, was that information disclosed to you?
If you answered "No" to any of the above questions, please explain.
Were you solicited by sales personnel in an educational room while you attended this educational activity?
If you answered "Yes" to the above question, please explain.
How much did you learn as a result of this educational program?
What did you learn during this activity that you intend to integrate into your practice?

What questions have arisen in your practice for which you need answers/strategies that you can implement?

What patient problems or patient challenges do you feel you are not able to address appropriately or to your satisfaction?
What problems are your patients communicating to you that need attention or follow up?

Are you interested in basic, intermediate or advanced level trainings?

What barriers might you have that would interfere with implementation of new information learned from this training?

How can this training be improved to better impact competence, performance and/or patient outcomes?

Additional comments:

Mr question